Mast cell-derived histamine and tumour necrosis factor: Differences between SJL/J and BALB/c inbred strains of mice

Immunology and Cell Biology

Volumn 74, Issue 3, 1996, Pages 225-230

  Bebo Jr , Bruce F ^a   Lee, Carol H ^b   Orr, Edward L ^b   Linthicum, D Scott ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

histamine; mast cells; tumour necrosis factor; vasoactive

Indexed keywords

HISTAMINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BRAIN DISEASE; BRAIN EDEMA; BRAIN INJURY; CELL GROWTH; HISTAMINE RELEASE; IMMUNE RESPONSE; IMMUNOMODULATION; MAST CELL; MOUSE; NONHUMAN;

EID: 0030013975     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1038/icb.1996.41     Document Type: Article

References (39)

1. Galli SJ, Dvorak AM, Dvorak HF. Basophils and mast cells: morphologic insights into their biology, secretory patterns, and function. Prog. Allergy 1984; 34: 1-141.
2. Schwartz LB, Austen KF. Structure and function of the chemical mediators of mast cells. Prog. Allergy 1984; 34: 271-321.
3. Haisa S, Chang HS, Bewtra AK et al. Long term cultured mouse mast cells: Ultrastructure, histamine and leukotriene levels. Int. Arch. Allergy Immunol. 1992; 98: 169-77.
4. Burd PR, Rogers HW, Gordon JR. Interleukin 3 dependent and independent mast cells stimulated with IgE and antigen express multiple cytokines. J. Exp. Med. 1989; 170: 245-57.
5. Gordon JR, Galli SJ. Mast cells as a source of both performed and immunologically inducible TNF-α/cachectin. Nature 346: 274-6.
6. Walsh L, Trinchieri G, Waldorf H, Whitaker D, Murphy G. Human dermal mast cells contain and release tumor necrosis factor α, which induces endothelial leukocyte adhesion molecule 1. Proc. Natl Acad. Sci. USA 1991; 88: 4220-4.
7. Klien LM, Lavker RM, Matis WL, Murphy GF. Degranulation of human mast cells induces an endothelial antigen central to leukocyte adhesion. Proc. Natl Acad. Sci. USA 1989; 86: 8972-6.
8. Yong T, Bebo BF Jr, Sapatino BV, Welsh CJ, Orr EL, Linthicum DS. Histamine-induced microvascular leakage in pial venules: Differences between the SJL/J and BALB/c inbred strains of mice. J. Neurotrauma 1994; 11: 161-71.
9. Orr E. Nervous-system-associated mast cells: Gatekeepers of neural and immune interactions. Drug. Der. Res. 1988; 15: 195-205.
10. Orr E. Presence and distribution of nervous system-associated mast cells that may modulate experimental autoimmune encephalomyelitis. Ann. NY Acad. Sci. 1989; 540: 723-6.
11. Linthicum DS, Munoz JJ, Blaskett A. Acute experimental autoimmune encephalomyelitis in mice. 1. The adjuvant action of Brodetella pertussis is due to vascoactive amine sensitization and increased vascular permeability of the central nervous system. Cell. Immunol. 1982; 73: 299-310.
12. Linthicum DS, Frelinger J. Acute autoimmune encephalomyelitis in mice. II. Susceptibility is controlled by the combination of H-2 and histamine sensitization genes. J. Exp. Med. 1982; 155: 31-40.
13. Razin E, Ihle JN, Seldin D et al. Interleukin 3: A differentiation and growth factor for the mouse mast cell that contains chondroitin sulfate E proteoglycan. J. Immunol. 1984; 132: 1479-86.
14. Dvorak AM, Galli SJ. Antigen induced, IgE mediated degranulation of cloned immature mast cells derived from normal mice. Am. J. Pathol. 1987; 126: 535-45.
15. Orr E, Pace K. The significance of mast cells as a source of histamine in the mouse brain. J. Neurochem. 1984; 42: 727-32.
16. Kitamura Y. Heterogeneity of mast cells and phenotypic changes between sub-populations. Ann. Rev. Immunol. 1989; 7: 59-76.
17. Beinenstock J, Befus D, Denberg J et al. Comparative aspects of mast cell heterogenity in different species and sites. Int. Arch. Allergy Appl. Immunol. 1985; 77: 126-9.
18. Galli SJ. New insights into 'the riddle of the mast cells': micorenvironmental regulation of mast cell development and phenotypic heterogeneity. Lab. Invest. 1990; 62: 5-33.
19. Askenase PW. Delayed-type hypersensitivity: Activation of mast cells by antigen-specific T cell factors initiates the cascade of cellular interactions. Immunol. Today 1983; 4: 259-64.
20. Askenase S, Bursztajn S, Gershon M, Gershon R. T cell-dependent mast cell degranulation and release of serotonin in murine delayed-type hypersensitivity. J. Exp. Med. 1980; 152: 1358-74.
21. Van Loveren H, Kraeuter-Kops S, Askenase P. Different mechanisms of release of vasoactive amines by mast cells in T cell-dependent compared to IgE-dependent cutaneous hypersensitivity responses. Eur. J. Immunol. 1984; 14: 40-7.
22. Van Loveren H, Kato K, Meade R et al. Characterization of two different LY-1 + T cell populations that mediate delayed-type hypersensitivity. J. Immunol. 1984; 133; 2402-11.
23. Sedgwick J, Brostoff S, Mason D. Experimental allergic encephalomyelitis in the absence of a classical delayed-type hypersensitivity reaction. J. Exp. Med. 1987; 165: 1058-75.
24. Askenase P, Rosenstein R, Ptak W. T cells produce an antigen-binding factor with in vivo activity analogous to IgE antibody. J. Exp. Med. 1983; 157: 862-73.
25. Powell H, Braheny S, Myers R, Rodriquez M, Lampert P. Early changes in experimental allergic neuritis. Lab. Invest. 1983; 48: 332-8.
26. Brosnan C, Lyman W, Tansey F, Carter T. Quantitation of mast cells in experimental allergic neuritis. J. Neuropathol. Exp. Neurol. 1985; 44: 196-203.
27. de Kozak Y, Sainte-Laudy J, Benveniste J, Faure J. Evidence for immediate hypersensitivity phenomena in experimental autoimmune uveoretinitis. Eur. J. Immunol. 1981; 11: 612-7.
28. Charcot JM. Lectures on Diseases of the Nervous System Delivered at la Salpetriere. (transl. G. Sigerson.) The New Sydenham Society, London, 1877.
29. Griffin D, Mendoza QP. Identification of the inflammatory cells present in the central nervous system of normal and mast cell-deficient mice during sindbis virus encephalitis. Cell. Immunol. 1896; 97: 454-9.
30. Babington R, Wedeking P. The influence of cinanserin and selected pharmacologic agents on experimental allergic encephalomyelitis (EAE). J. Pharm. Exp. Therap. 1971; 177: 455-60.
31. Linthicum DS. Development of acute experimental autoimmune encephalomyelitis in mice: Factors regulating the effector phase of the disease. Immunobiol. 1982; 162: 220-1.
32. Waxman F, Taguiam J, Whitacre C. Modification of the clinical and histopathologic expression of experimental allergic encephalomyelitis by the vasoactive amine antagonist cyproheptadine. Cell. Immunol. 1984; 85: 82-93.
33. Dietsch GN, Hinrichs DJ. The role of mast cells in the elicitation of experimental allergic encephalomyelitis. J. Immunology 1989; 142: 1476-81.
34. Orr E, Stanley N. Brain and spinal cord levels of histamine in lewis rats with acute experimental autoimmune encephalomyelitis. J Neurochem. 1989; 53: 111-8.
35. Johnson D, Yasugi D, Seeldrayers P. An analysis of mast cell frequency in the rodent nervous system: Numbers vary between different strains and can be reconstituted in mast cell deficient mice. J. Neuropath. Exp. Neurol. 1991; 50: 227-34.
36. Dimlich R, Keller J, Strauss T, Fritts M. Linear arrays of homogenous mast cells in the dura mater of the rat. J. Neurocytol. 1991; 20: 485-503.
37. Waksman B. Autoimmunity in demyelinating disease. Ann. N.Y. Acad. Sci. 1988; 540: 13-24.
38. Bienenstock J, Tomioka M, Matsuda H. The role of mast cells in inflammatory processes: Evidence for nerve/mast cell interactions. Int. Archs Allergy Appl. Immun. 1987; 82: 238-43.
39. Kruger PG, Bo L, Myhr KM. Mast cells and multiple sclerosis: A light and electron microscopic study of mast cells in multiple sclerosis emphasizing staining procedures. Acta Neurol. Scand. 1990; 81: 31-6.